(Date:12/2/2009)... , SINGAPORE, Dec. 2 S*BIO Pte ...l oral JAK2 inhibitor, SB1518, at The American Soc...ion in New Orleans. ,, Data will be presented o...ation trial of SB1518 detailing its safety, tolera... profile in dose levels ranging from 100 to 600 mg...
(Date:12/2/2009)..., SHANGHAI, Dec. 2 /PRNewswire-Asia/ -- The w... are in turmoil and uncertainty is part of many,bu...rma industry has been,relatively immune to the eco...ation. , During the midst of the difficul...n & Johnson inaugurated an R&D center in S...
(Date:12/1/2009)...NCLINE VILLAGE, Nev., Dec. 1 /PRNewswire-FirstCall...day announced revenue guidance for the fourth quar...illion, as compared with $69 million for the fourt... results was the first of two installment payments...fourth quarter 2008 results was a one-time $1.8 mi...
(Date:12/1/2009)...PLYMOUTH, Mass., Dec. 1 Harvest Te... today results from the company sponsored 60-patie...ical Center in Chennai, India using the company,s ...able Critical Limb Ischemia (CLI). Sri Ramachandra...-associated institution based in Chennai, India an...
Breaking Biology Technology:S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 2PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 3Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia 2Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia 3...VER, Mass., Oct. 8 Millstone Medical Outsourcing,...cility in Fall River, MA,to accommodate growing bu...w for additional clean room operations. The new fa...,000 square feet of space that allows,increased ca...c cleaning,and sterile and non-sterile packaging. ...
...HMOND, Calif., Oct. 8 Transcept Pharmaceuticals,I...pany, announced today,that Thomas P. Soloway, Seni...cheduled to present at the Natixis Bleichroeder Se...y on Monday, October 13, 2008 at 9:30 AM,Eastern T...e available at, http://www.wsw.com/webcast/nblr2/t...
...e Review With Drs. William F. Fearon, Morton J. Ke...the Highlights, WILMINGTON, Massachusetts, Octobe...optimizing patient outcomes is the topic,of multip...cular,Therapeutics symposium, TCT 2008, which will...Medical Systems, the first company to develop syst...
Other Biology Technology:Millstone Medical Outsourcing Acquires New Facility to Accommodate Growing Business, Provide Additional Clean Room Capacity 2Transcept Pharmaceuticals, Inc. to Present at the Natixis Bleichroeder Second Annual Hidden Gems Conference 2Radi Medical Systems Announces Schedule for TCT 2008 2Random DNA mutagenesis Service from Yorkshire Bioscience Ltd
...ed solution for scheduling, performing and documen...ing for all pipettes and liquid handling devices. ...orts all gravimetric calibration protocols Meets...irements Includes setup information for balances...
...ee plasmid DNA preparations are prepared from cust...1mg to multi-gram scales. Small-scale (1-100mg) a...ons are made according to customer specifications....omer needs, and glycerol stocks are maintained to ...
...ones which belong to the transforming growth facto...arge group of extra-cellular growth factors which ...function and tumor formation (1). Other members in...fferentiation factors, AMH/MIS (Anti-Mullerian Hor...
Biology Products: